Tucatinib Together With Pembrolizumab and Trastuzumab
Clinical trial NCT04789096 · TERMINATED
Trial details
- NCT number
- NCT04789096
- Sponsor
- Breast Cancer Trials, Australia and New Zealand
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2025-06-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.